3043 companies

Verde Science

Market Cap: US$23.0

A pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions.

VRCI

US$0.000001

7D

0%

1Y

n/a

Regnum

Market Cap: US$22.0

Develops and commercializes therapeutics that treat rare and infectious diseases.

RGMP

US$0.000001

7D

0%

1Y

-100.0%

Corix Bioscience

Market Cap: US$20.0

Provides cannabidiol (CBD) oil for various medicinal purposes.

CXBS

US$0.000001

7D

0%

1Y

n/a

VIA Pharmaceuticals

Market Cap: US$20.0

A development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases.

VIAP

US$0.000001

7D

0%

1Y

n/a

Affimed

Market Cap: US$16.0

A clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany.

AFMD.Q

US$0.0001

7D

0%

1Y

-100.0%

Tibet Pharmaceuticals

Market Cap: US$14.0

A specialty pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Tibetan medicines.

TBET

US$0.000001

7D

0%

1Y

n/a

IMV

Market Cap: US$14.0

Operates as a clinical-stage immuno-oncology company.

IMVI.F

US$0.000001

7D

0%

1Y

n/a

BG Medicine

Market Cap: US$11.0

Engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States.

BGMD

US$0.000001

7D

0%

1Y

n/a

Adhera Therapeutics

Market Cap: US$11.0

A biotech company, focuses on the discovery, development, and commercialization of small molecule drugs.

ATRX

US$0.000001

7D

0%

1Y

-99.0%

Proteonomix

Market Cap: US$7.0

A biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives.

PROT

US$0.000001

7D

0%

1Y

n/a

VioQuest Pharmaceuticals

Market Cap: US$6.0

VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases.

VOQP

US$0.000001

7D

0%

1Y

n/a

Stem Holdings

Market Cap: US$6.0

Does not have significant operations.

STMH

US$0.000001

7D

0%

1Y

0%

Adynxx

Market Cap: US$5.0

A clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases.

ADYX

US$0.000001

7D

0%

1Y

n/a

Acusphere

Market Cap: US$4.0

Operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs.

ACUS

US$0.000001

7D

0%

1Y

n/a

Synvista Therapeutics

Market Cap: US$2.0

A product-based biopharmaceutical company, develops diagnostic tests and drugs to identify and treat diabetic patients at high risk for the development of cardiovascular disease.

SYNI

US$0.000001

7D

0%

1Y

n/a

Cannalink

Market Cap: US$0

A development stage company that intends to develop cannabidiol based products and provide services to emerging companies in the medical marijuana and industrial healthcare sector.

CNLK

US$0.0002

7D

0%

1Y

n/a

Dannex Ayrton Starwin

Market Cap: GH₵0

Manufactures and sells pharmaceutical products in Ghana.

DASPHARMA

GH₵0.38

7D

0%

1Y

0%

G-H-3 International

Market Cap: US$0

Develops products for addressing factors, which cause aging and deterioration in the body.

GHTI

US$0.000001

7D

0%

1Y

n/a

PJSC Ozon Pharmaceuticals

Market Cap: ₽0

Manufactures and sells pharmaceutical products.

OZPH

₽32.50

7D

n/a

1Y

n/a

Page 85 of 85